Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-15 Sale |
2021-11-17 5:00 pm |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
20,176 | $17.93 | $361,690 | 212,849 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-17 5:00 pm |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
8,000 | $18.05 | $144,400 | 104,038 (Direct) |
View |
| 2021-11-11 Sale |
2021-11-15 5:00 pm |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
20,000 | $15.07 | $301,354 | 199,038 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-05 7:21 pm |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
1,251 | $14.21 | $17,783 | 70,888 (Direct) |
View |
| 2021-09-23 Sale |
2021-09-27 4:30 pm |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
20,000 | $15.23 | $304,646 | 199,838 (Direct) |
View |
| 2021-09-24 Purchase |
2021-09-27 4:30 pm |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
3,400 | $14.72 | $50,051 | 55,377 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 4:00 pm |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
13,439 | $15.1 | $202,894 | 269,573 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 8:44 pm |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
20,274 | $15.13 | $306,767 | 150,286 (Direct) |
View |
| 2021-01-20 Sale(A) |
2021-02-18 8:40 pm |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
2,720 | $15.07 | $40,980 | 19,280 (Direct) |
View |
| 2021-01-20 Purchase |
2021-01-22 4:33 pm |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
2,720 | $15.07 | $40,980 | 4,720 (Direct) |
View |
| 2020-11-24 Purchase |
2020-11-25 4:09 pm |
Cue Biopharma Inc. | CUE | Fletcher Aaron G.L. Director |
6,548 | $12.64 | $82,776 | 173,867 (Indirect Direct) |
View |
| 2020-09-29 Purchase |
2020-10-01 4:13 pm |
Cue Biopharma Inc. | CUE | Gray Cameron Director |
10,000 | $15.15 | $151,500 | 677,500 (Direct) |
View |
| 2020-08-05 Sale(A) |
2020-08-10 4:03 pm |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,374 | $20 | $267,480 | 147,125 (Direct) |
View |
| 2020-08-05 Sale |
2020-08-07 5:44 pm |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,274 | $20 | $265,480 | 147,225 (Direct) |
View |
| 2020-08-05 Sale |
2020-08-07 5:41 pm |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
800 | $20.01 | $16,008 | 179,558 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:51 pm |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
6,626 | $20 | $132,530 | 304,074 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:50 pm |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
6,200 | $20.02 | $124,114 | 344,558 (Direct) |
View |
| 2020-06-24 Purchase |
2020-06-25 4:01 pm |
Cue Biopharma Inc. | CUE | Fletcher Aaron G.L. Director |
7,500 | $24.88 | $186,572 | 167,319 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-12-20 Option Award |
2021-12-21 4:05 pm |
N/A 2031-12-20 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 5:00 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
20,176 | $2.86 | 212,849 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 5:00 pm |
N/A 2023-03-23 |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
20,176 | $0 | 212,849 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 5:00 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
8,000 | $8.26 | 104,038 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 5:00 pm |
N/A 2025-08-14 |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
8,000 | $0 | 104,038 (Direct) |
View |
| 2021-11-11 Exercise |
2021-11-15 5:00 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
20,000 | $6.42 | 199,038 (Direct) |
View |
| 2021-11-11 Exercise |
2021-11-15 5:00 pm |
N/A 2029-03-06 |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
20,000 | $0 | 199,038 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-08 4:00 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
31,677 | $14.57 | 173,700 (Direct) |
View |
| 2021-09-30 Exercise |
2021-10-08 4:00 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
75,000 | $0 | 173,700 (Direct) |
View |
| 2021-10-06 Tax Withholding |
2021-10-08 4:00 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
14,134 | $12.97 | 94,038 (Direct) |
View |
| 2021-10-03 Exercise |
2021-10-08 4:00 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
33,334 | $0 | 94,038 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 7:21 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
1,251 | $7.5 | 70,888 (Direct) |
View |
| 2021-08-23 Exercise |
2021-10-05 7:21 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
7,918 | $0 | 70,888 (Direct) |
View |
| 2021-08-23 Tax Withholding |
2021-10-05 7:21 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
1,961 | $0 | 70,888 (Direct) |
View |
| 2021-09-23 Exercise |
2021-09-27 4:30 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
20,000 | $6.42 | 199,838 (Direct) |
View |
| 2021-09-23 Exercise |
2021-09-27 4:30 pm |
N/A 2029-03-06 |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
20,000 | $0 | 199,838 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-17 4:00 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
13,439 | $5 | 269,573 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-17 4:00 pm |
N/A 2024-04-17 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
13,439 | $0 | 269,573 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-18 8:44 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
2,994 | $5 | 150,286 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 8:44 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
17,280 | $2.86 | 150,286 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 8:44 pm |
N/A 2023-11-16 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
20,274 | $0 | 150,286 (Direct) |
View |
| 2021-01-20 Exercise(A) |
2021-02-18 8:40 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
2,720 | $2.86 | 19,280 (Direct) |
View |
| 2021-01-20 Exercise(A) |
2021-02-18 8:40 pm |
N/A 2023-11-16 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
2,720 | $0 | 19,280 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:52 pm |
N/A 2031-02-09 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:49 pm |
N/A 2031-02-09 |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:47 pm |
N/A 2031-02-09 |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CEO |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:43 pm |
N/A 2031-02-09 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:43 pm |
N/A 2031-02-09 |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CFO |
70,000 | $0 | 70,000 (Direct) |
View |
| 2020-12-02 Ownership |
2021-02-01 5:41 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Gray Cameron Director |
1,029,800 | $0 | 352,300 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:46 pm |
N/A 2031-01-03 |
Cue Biopharma Inc. | CUE | Simon Barry J. Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:44 pm |
N/A 2031-01-03 |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:44 pm |
N/A 2031-01-03 |
Cue Biopharma Inc. | CUE | DRISCOLL FREDERICK W Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:41 pm |
N/A 2031-01-03 |
Cue Biopharma Inc. | CUE | Morich Frank Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:39 pm |
N/A 2031-01-03 |
Cue Biopharma Inc. | CUE | Fletcher Aaron G.L. Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:39 pm |
N/A 2031-01-03 |
Cue Biopharma Inc. | CUE | Gray Cameron Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:39 pm |
N/A 2031-01-03 |
Cue Biopharma Inc. | CUE | HOWSON TAMAR D Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-10-05 Tax Withholding |
2020-10-06 5:08 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
9,800 | $16.3 | 91,425 (Direct) |
View |
| 2020-10-03 Exercise |
2020-10-06 5:08 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
33,333 | $0 | 91,425 (Direct) |
View |
| 2020-09-17 Option Award |
2020-09-18 4:15 pm |
N/A 2030-09-17 |
Cue Biopharma Inc. | CUE | HOWSON TAMAR D Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-08-21 Option Award |
2020-08-25 4:12 pm |
N/A 2030-08-21 |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CFO |
85,000 | $0 | 104,100 (Direct) |
View |
| 2020-08-21 Exercise |
2020-08-25 4:12 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CFO |
6,666 | $0 | 104,100 (Direct) |
View |
| 2020-08-24 Tax Withholding |
2020-08-25 4:12 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CFO |
1,900 | $0 | 104,100 (Direct) |
View |
| 2020-08-05 Exercise(A) |
2020-08-10 4:03 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,374 | $7.5 | 147,125 (Direct) |
View |
| 2020-08-05 Exercise(A) |
2020-08-10 4:03 pm |
N/A 2024-12-27 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,374 | $0 | 147,125 (Direct) |
View |
| 2020-08-05 Exercise |
2020-08-07 5:44 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,274 | $7.5 | 147,225 (Direct) |
View |
| 2020-08-05 Exercise |
2020-08-07 5:44 pm |
N/A 2024-12-27 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
13,274 | $0 | 147,225 (Direct) |
View |
| 2020-08-05 Exercise |
2020-08-07 5:41 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
800 | $6.42 | 179,558 (Direct) |
View |
| 2020-08-05 Exercise |
2020-08-07 5:41 pm |
N/A 2029-03-06 |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
800 | $0 | 179,558 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:51 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
6,626 | $7.5 | 304,074 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:51 pm |
N/A 2024-12-27 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec |
6,626 | $0 | 304,074 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:50 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
4,200 | $6.42 | 344,558 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:50 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
2,000 | $8.26 | 344,558 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:50 pm |
N/A 2025-08-14 |
Cue Biopharma Inc. | CUE | Suri Anish President and CSO |
6,200 | $0 | 344,558 (Direct) |
View |
| 2020-05-11 Option Award |
2020-05-12 4:18 pm |
2020-12-31 2030-05-11 |
Cue Biopharma Inc. | CUE | Morich Frank Director |
1,200 | $0 | 1,200 (Direct) |
View |